E-ISSN 2534-9821
 

Original Research 


Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.

Pragathi Kottapalli, Srinivas Kishore Sistla, SivaRam Nunna, Naveen Chander Reddy Podduturi, Sadhana Yelamanchili Veturi, Naveen Admala, Aswini Deborah.

Abstract
Aim: India has reported a recent surge in Mucormycosis cases. Prevention of COVID-19 associated Mucormycosis needs to focus on aiming for better glycemic control in COVID-19 patients and monitoring the use of systemic corticosteroids in treating severe cases. This study is an attempt to evaluate various patient characteristics that could contribute to Mucormycosis among COVID and post COVID patients.
Materials and Methods: A retrospective observational study was carried out at a tertiary Care Hospital during April 2021–June 2021. After obtaining approval from Institutional Ethics committee, various demographic and clinical details of all patients, such as diabetes mellitus, use of steroids in COVID-19 treatment, use of immunosuppressant drugs, oxygen therapy etc., were noted. All Mucormycosis patients were treated with Amphotericin B and aggressive surgical treatment.
Results: In the present study, majority of the patients who developed COVID associated Mucormycosis were treated in Private Hospitals (65, 62.5 %) for COVID -19 disease . About 78.89 % of Mucormycosis patients were males. In majority of the patient’s onset of symptoms of Mucormycosis was seen during the first week (56 %).Most patients were between 51-60 years (32.1 %). Among risk factors, 91.7 % had COVID-19 infection, 90.47% had received steroids, 80 % had diabetes mellitus and 47.11 % had received oxygen. About 37 % of patients presented in stage III and 35 % presented in stage I and II. In our study mortality was very less compared to other studies ( 12.35 %.).
Conclusion: There is a complex association between COVID -19 and Mucormycosis.The main predisposing factor was use of steroids during the treatment of COVID-19 which led to uncontrolled diabetes mellitus predisposing to Mucormycosis.

Key words: COVID – 19, Mucormycosis, Rhino Orbital Cerebral Mucormycosis, Diabetes


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pragathi Kottapalli
Articles by Srinivas Kishore Sistla
Articles by SivaRam Nunna
Articles by Naveen Chander Reddy Podduturi
Articles by Sadhana Yelamanchili Veturi
Articles by Naveen Admala
Articles by Aswini Deborah
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Kottapalli P, Sistla SK, Nunna S, Podduturi NCR, Veturi SY, Admala N, Deborah A. Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. Int J Med Rev Case Rep. 2022; 6(15): 79-85. doi:10.5455/IJMRCR.172-1660903934


Web Style

Kottapalli P, Sistla SK, Nunna S, Podduturi NCR, Veturi SY, Admala N, Deborah A. Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. https://www.mdpub.net/?mno=107346 [Access: December 05, 2023]. doi:10.5455/IJMRCR.172-1660903934


AMA (American Medical Association) Style

Kottapalli P, Sistla SK, Nunna S, Podduturi NCR, Veturi SY, Admala N, Deborah A. Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. Int J Med Rev Case Rep. 2022; 6(15): 79-85. doi:10.5455/IJMRCR.172-1660903934



Vancouver/ICMJE Style

Kottapalli P, Sistla SK, Nunna S, Podduturi NCR, Veturi SY, Admala N, Deborah A. Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. Int J Med Rev Case Rep. (2022), [cited December 05, 2023]; 6(15): 79-85. doi:10.5455/IJMRCR.172-1660903934



Harvard Style

Kottapalli, P., Sistla, . S. K., Nunna, . S., Podduturi, . N. C. R., Veturi, . S. Y., Admala, . N. & Deborah, . A. (2022) Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. Int J Med Rev Case Rep, 6 (15), 79-85. doi:10.5455/IJMRCR.172-1660903934



Turabian Style

Kottapalli, Pragathi, Srinivas Kishore Sistla, SivaRam Nunna, Naveen Chander Reddy Podduturi, Sadhana Yelamanchili Veturi, Naveen Admala, and Aswini Deborah. 2022. Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. International Journal of Medical Reviews and Case Reports, 6 (15), 79-85. doi:10.5455/IJMRCR.172-1660903934



Chicago Style

Kottapalli, Pragathi, Srinivas Kishore Sistla, SivaRam Nunna, Naveen Chander Reddy Podduturi, Sadhana Yelamanchili Veturi, Naveen Admala, and Aswini Deborah. "Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.." International Journal of Medical Reviews and Case Reports 6 (2022), 79-85. doi:10.5455/IJMRCR.172-1660903934



MLA (The Modern Language Association) Style

Kottapalli, Pragathi, Srinivas Kishore Sistla, SivaRam Nunna, Naveen Chander Reddy Podduturi, Sadhana Yelamanchili Veturi, Naveen Admala, and Aswini Deborah. "Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.." International Journal of Medical Reviews and Case Reports 6.15 (2022), 79-85. Print. doi:10.5455/IJMRCR.172-1660903934



APA (American Psychological Association) Style

Kottapalli, P., Sistla, . S. K., Nunna, . S., Podduturi, . N. C. R., Veturi, . S. Y., Admala, . N. & Deborah, . A. (2022) Mucormycosis in COVID-19 - Evaluation of associated risk factors at a tertiary care centre.. International Journal of Medical Reviews and Case Reports, 6 (15), 79-85. doi:10.5455/IJMRCR.172-1660903934